These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 20674999)
1. Clinical implications of switching from intensive to moderate statin therapy after acute coronary syndromes. Colivicchi F; Tubaro M; Santini M Int J Cardiol; 2011 Oct; 152(1):56-60. PubMed ID: 20674999 [TBL] [Abstract][Full Text] [Related]
2. Effect of intensive statin therapy on clinical outcomes among patients undergoing percutaneous coronary intervention for acute coronary syndrome. PCI-PROVE IT: A PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) Substudy. Gibson CM; Pride YB; Hochberg CP; Sloan S; Sabatine MS; Cannon CP; J Am Coll Cardiol; 2009 Dec; 54(24):2290-5. PubMed ID: 19958964 [TBL] [Abstract][Full Text] [Related]
3. Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trial. Ray KK; Cannon CP; McCabe CH; Cairns R; Tonkin AM; Sacks FM; Jackson G; Braunwald E; J Am Coll Cardiol; 2005 Oct; 46(8):1405-10. PubMed ID: 16226162 [TBL] [Abstract][Full Text] [Related]
4. Rationale and design of China intensive lipid lowering with statins in acute coronary syndrome: the CHILLAS study. Zhao SP; Peng DQ; Yu BL; Huo Y; Am Heart J; 2009 Oct; 158(4):509-512.e1. PubMed ID: 19781407 [TBL] [Abstract][Full Text] [Related]
5. Reduction in recurrent cardiovascular events with intensive lipid-lowering statin therapy compared with moderate lipid-lowering statin therapy after acute coronary syndromes from the PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) trial. Murphy SA; Cannon CP; Wiviott SD; McCabe CH; Braunwald E J Am Coll Cardiol; 2009 Dec; 54(25):2358-62. PubMed ID: 20082923 [TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy. Silva M; Matthews ML; Jarvis C; Nolan NM; Belliveau P; Malloy M; Gandhi P Clin Ther; 2007 Feb; 29(2):253-60. PubMed ID: 17472818 [TBL] [Abstract][Full Text] [Related]
7. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. Cannon CP; Braunwald E; McCabe CH; Rader DJ; Rouleau JL; Belder R; Joyal SV; Hill KA; Pfeffer MA; Skene AM; N Engl J Med; 2004 Apr; 350(15):1495-504. PubMed ID: 15007110 [TBL] [Abstract][Full Text] [Related]
8. Effect of intensive lipid-lowering therapy on mortality after acute coronary syndrome (a patient-level analysis of the Aggrastat to Zocor and Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 trials). Murphy SA; Cannon CP; Wiviott SD; de Lemos JA; Blazing MA; McCabe CH; Califf RM; Braunwald E Am J Cardiol; 2007 Oct; 100(7):1047-51. PubMed ID: 17884359 [TBL] [Abstract][Full Text] [Related]
9. The effect of moderate-dose versus double-dose statins on patients with acute coronary syndrome in China: Results of the CHILLAS trial. Zhao SP; Yu BL; Peng DQ; Huo Y Atherosclerosis; 2014 Apr; 233(2):707-712. PubMed ID: 24603217 [TBL] [Abstract][Full Text] [Related]
10. Prognostic utility of apoB/AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE IT-TIMI 22. Ray KK; Cannon CP; Cairns R; Morrow DA; Ridker PM; Braunwald E Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):424-30. PubMed ID: 19122170 [TBL] [Abstract][Full Text] [Related]
11. Statin-associated rhabdomyolysis: is there a dose-response relationship? Holbrook A; Wright M; Sung M; Ribic C; Baker S Can J Cardiol; 2011; 27(2):146-51. PubMed ID: 21459261 [TBL] [Abstract][Full Text] [Related]
12. Focused atorvastatin therapy in managed-care patients with coronary heart disease and CKD. Koren MJ; Davidson MH; Wilson DJ; Fayyad RS; Zuckerman A; Reed DP; Am J Kidney Dis; 2009 May; 53(5):741-50. PubMed ID: 19216014 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of atorvastatin/fenofibrate fixed-dose combination tablet compared with atorvastatin and fenofibrate monotherapies in patients with dyslipidemia: a 12-week, multicenter, double-blind, randomized, parallel-group study. Davidson MH; Rooney MW; Drucker J; Eugene Griffin H; Oosman S; Beckert M; Clin Ther; 2009 Dec; 31(12):2824-38. PubMed ID: 20110022 [TBL] [Abstract][Full Text] [Related]
14. Effect of intensive vs standard statin therapy on endothelial progenitor cells and left ventricular function in patients with acute myocardial infarction: Statins for regeneration after acute myocardial infarction and PCI (STRAP) trial. Leone AM; Rutella S; Giannico MB; Perfetti M; Zaccone V; Brugaletta S; Garramone B; Niccoli G; Porto I; Liuzzo G; Biasucci LM; Bellesi S; Galiuto L; Leone G; Rebuzzi AG; Crea F Int J Cardiol; 2008 Nov; 130(3):457-62. PubMed ID: 18667247 [TBL] [Abstract][Full Text] [Related]
15. Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy. Corrao G; Conti V; Merlino L; Catapano AL; Mancia G Clin Ther; 2010 Feb; 32(2):300-10. PubMed ID: 20206788 [TBL] [Abstract][Full Text] [Related]
16. Pregnancy-associated plasma protein-A elevation in patients with acute coronary syndrome and subsequent atorvastatin therapy. Miedema MD; Conover CA; MacDonald H; Harrington SC; Oberg D; Wilson D; Henry TD; Schwartz RS Am J Cardiol; 2008 Jan; 101(1):35-9. PubMed ID: 18157962 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of intensive statin therapy in the elderly. Maroo BP; Lavie CJ; Milani RV Am J Geriatr Cardiol; 2008; 17(2):92-100. PubMed ID: 18326948 [TBL] [Abstract][Full Text] [Related]
18. Comparison of atorvastatin 80 mg/day versus simvastatin 20 to 40 mg/day on frequency of cardiovascular events late (five years) after acute myocardial infarction (from the Incremental Decrease in End Points through Aggressive Lipid Lowering [IDEAL] trial). Pedersen TR; Cater NB; Faergeman O; Kastelein JJ; Olsson AG; Tikkanen MJ; Holme I; Larsen ML; Lindahl C; Szarek M Am J Cardiol; 2010 Aug; 106(3):354-9. PubMed ID: 20643245 [TBL] [Abstract][Full Text] [Related]
19. Impact of the pravastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction 22/Reversal of Atherosclerosis with Aggressive Lipid Lowering trials on trends in intensive versus moderate statin therapy in Ontario, Canada. Austin PC; Mamdani MM Circulation; 2005 Aug; 112(9):1296-300. PubMed ID: 16116054 [TBL] [Abstract][Full Text] [Related]
20. Discontinuation of statin therapy and clinical outcome after ischemic stroke. Colivicchi F; Bassi A; Santini M; Caltagirone C Stroke; 2007 Oct; 38(10):2652-7. PubMed ID: 17761916 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]